The importance of validating the diagnosis of coronary heart disease when measuring secondary prevention:a cross-sectional study in general practice


Autoria(s): Connolly, Paul; Cupples, Margaret E; Cuene-Grandidier, Hazel; Johnston, Dennis; Passmore, Peter
Data(s)

2002

Resumo

To compare levels of recorded risk factors and drug treatment between patients with validated and non-validated diagnoses of coronary heart disease (CHD) in Northern Ireland.

Identificador

http://pure.qub.ac.uk/portal/en/publications/the-importance-of-validating-the-diagnosis-of-coronary-heart-disease-when-measuring-secondary-prevention(04d5b45d-ffdf-4ffc-8df1-be4c0075a5bb).html

http://dx.doi.org/10.1002/pds.709

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Connolly , P , Cupples , M E , Cuene-Grandidier , H , Johnston , D & Passmore , P 2002 , ' The importance of validating the diagnosis of coronary heart disease when measuring secondary prevention : a cross-sectional study in general practice ' Pharmacoepidemiology and Drug Safety , vol 11 , no. 4 , pp. 311-7 . DOI: 10.1002/pds.709

Palavras-Chave #/dk/atira/pure/subjectarea/asjc/2700/2736 #Pharmacology (medical) #/dk/atira/pure/subjectarea/asjc/3000 #Pharmacology, Toxicology and Pharmaceutics(all)
Tipo

article